BPA Call HHSN263201100088B-HHSN26100003
- Waters Technologies Corporation, a subsidiary of Waters Corporation headquartered in Milford, Massachusetts, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on March 10, 2016, with a ceiling value of $7,173.76 and an ultimate completion date of March 20, 2016. This firm fixed-price contract was issued without a small business set-aside designation and is performed at the NCI's facility in Bethesda, Maryland. The award represents a task order call...
- Waters Technologies Corporation, a subsidiary of Waters Corporation, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute valued at $12,871.78 with a completion date of December 29, 2014. This contract, issued under a firm fixed-price arrangement without set-aside designation, represents a task order call against Waters' existing BPA vehicle under the General Services Administration's Scientific Equipment and Services Multiple Award Schedule. The National...
- Waters Technologies Corporation, a subsidiary of global analytical instrumentation leader Waters Corporation, received a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $13,137.80 from the National Cancer Institute (NCI) for maintenance services. Awarded on December 30, 2015, with an ultimate completion date of December 29, 2016, this contract was issued without a small business set-aside designation. The work is to be performed in Bethesda, Maryland, where NCI maintains its...
- Waters Technologies Corporation was awarded a limited service plan contract by the National Cancer Institute (NCI) for maintenance services on one PM MX6NM3814M instrument, with a ceiling value of $4,283.11. This fixed-price contract with economic price adjustment was executed as a Blanket Purchase Agreement (BPA) call, effective January 11, 2015 through January 10, 2016, with performance conducted at NCI facilities in Bethesda, Maryland. The contract was awarded without a set-aside designation,...
- Waters Technologies Corporation received a modification to de-obligate funds from fiscal year 2016 expiring lines under a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute. The contract modification, valued at $17,396.64 on a firm fixed-price basis, has an ultimate completion date of May 1, 2021. Waters Technologies Corporation, a subsidiary of Waters Corporation headquartered in Milford, Massachusetts, is a leading provider of advanced analytical instrumentation...
- The National Cancer Institute awarded Waters Technologies Corporation a $55,280.73 fixed-price contract with economic price adjustment on June 27, 2014, for an ACQUITY CDA Detector (Standard) under a Blanket Purchase Agreement call structure. The contract, which completed on July 9, 2014, was performed at Research Triangle Park, North Carolina, and involved no small business set-aside designation. Waters Technologies Corporation, a subsidiary of Waters Corporation headquartered in Milford,...
- The National Cancer Institute awarded a delivery order valued at $40,068.51 to Waters Technologies Corporation, a subsidiary of Waters Corporation, for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026 closing of the period of availability for these funds. This firm fixed-price delivery order was issued under the General Services Administration's Multiple Award Schedule contract vehicle and was completed by March 31,...
- The National Cancer Institute issued a BPA call to Waters Technologies Corporation on September 19, 2017, with a ceiling value of $14,651.44 under a fixed-price contract with economic price adjustment provisions. The call was completed by September 18, 2018. Place of performance was Bethesda, Maryland. The source does not identify the parent BPA by name or describe its scope. Waters Technologies Corporation is a subsidiary of Waters Corporation, a global manufacturer of analytical...
- The National Cancer Institute awarded a $55.8K delivery order to Waters Technologies Corporation for FY26 Waters Instrumentation service agreement, with performance to be completed by September 26, 2025. This is a firm fixed-price contract with no set-aside designation, issued under Waters' established General Services Administration Multiple Award Schedule vehicle. The work will be performed in North Bethesda, Maryland, and represents a continuation of Waters' role as a primary supplier of...
- This federal contract award, valued at $14,189.63, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Waters Technologies Corporation, doing business as Waters. The contract is a Blanket Purchase Agreement (BPA) call for a maintenance agreement on Waters laboratory instruments, specifically the CO2SAT489T SATIN (BREEZE) WATERS QUOTE 20921518, with a total assurance plan including one preventative maintenance visit. The...
- Scientific Equipment and Services (FSS-66)Master GSA Schedule
- GS07F0559X-HHSN263201100088BBlanket Purchase Agreement
- HHSN263201100088B-HHSN26100003BPA Call
Waters Technologies Corporation, a subsidiary of Waters Corporation, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute valued at $28,889.53 with a firm fixed-price structure. The contract was awarded on February 7, 2014, with an ultimate completion date of April 7, 2015, with no small business set-aside designation. This BPA call falls under the General Services Administration's Scientific Equipment and Services Multiple Award Schedule (FSS-66), leveraging the parent company's established master contract vehicle to procure specialized laboratory equipment and services for federal research initiatives. The award reflects Waters Technologies Corporation's capability to supply the National Cancer Institute with advanced analytical instrumentation and support services, consistent with the company's core business of providing liquid chromatography, mass spectrometry, and related laboratory technologies to federal agencies. Waters Technologies Corporation maintains its place of performance in Milford, Massachusetts, where the parent organization is headquartered, ensuring direct access to technical expertise and manufacturing capabilities for the National Cancer Institute's research and diagnostic requirements.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Scientific Equipment and Services | 7FCB-C4-070066-B | GSA Federal Acquisition Service | Award Notice 9/33 | 10/4/11, 1:23 PM | |
Scientific Equipment and Services | 7FCB-C4-070066-B | GSA Federal Acquisition Service | Award Notice 27/33 | 6/13/18, 6:01 PM | |
Scientific Equipment & Services | 7FCB-C4-07-0066-B | GSA Federal Acquisition Service | Award Notice 12/33 | 1/18/12, 1:05 PM | |
SCIENTIFIC EQUIPMENT AND SERVICES | 7FCB-C4-07-0066-B | GSA Federal Acquisition Service | Award Notice 20/33 | 5/4/12, 4:00 PM | |
Scientific Equipment and Supplies | 7FCB-C4-07-0066-B | GSA Federal Acquisition Service | Award Notice 2/33 | 8/31/10, 1:31 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.9k | 2/7/14 |